Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Robert A. Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Medicine, Gynecology, Oncology +11

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy Perren, Ann Marie Swart, Jacobus Pfisterer et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +11

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Willemien J. van Driel, Simone N. Koole, Karolina Sikorska et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Oncology, Surgery +14

Risk Factors for Anastomotic Leakage after Surgery for Colorectal Cancer: Results of Prospective Surveillance

Tsuyoshi Konishi, Toshiaki Watanabe, Junji Kishimoto et al. · Journal of the American College of Surgeons · 2006 · 291 citations

Medicine, Oncology, Surgery +17

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas

S. Dennis, Oliver Zivanovic, Kimberly Levinson et al. · Gynecologic Oncology · 2010 · 196 citations

Medicine, Gynecology, Surgery +15